Literature DB >> 25794951

Vagal modulation of hypertension.

Bradley W Petkovich1, Joshua Vega, Sabu Thomas.   

Abstract

Resistant hypertension despite compliance with pharmacologic therapies continues to hamper optimal blood pressure control. Vagal modulation via direct stimulation of the body's parasympathetic nervous system is proving a promising therapeutic modality to help patients achieve their blood pressure goals. In this article, we review some of the key concepts of different vagal modulations for resistant hypertension including baroreflex activation therapy, renal sympathetic denervation, and direct vagal nerve stimulation.

Entities:  

Mesh：

Year:  2015        PMID： 25794951     DOI： 10.1007/s11906-015-0532-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  24 in total

1.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

2.  An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

Authors:  Karl A Illig; Mark Levy; Luis Sanchez; Gregory D Trachiotis; Charles Shanley; Eric Irwin; Terry Pertile; Robert Kieval; Robert Cody
Journal:  J Vasc Surg       Date:  2006-12       Impact factor: 4.268

3.  Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery.

Authors:  Jürg Schmidli; Hannu Savolainen; Friedrich Eckstein; Eric Irwin; Tim K Peters; Roy Martin; Robert Kieval; Robert Cody; Thierry Carrel
Journal:  Vascular       Date:  2007 Mar-Apr       Impact factor: 1.285

Review 4.  Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy.

Authors:  Brian Olshansky; Hani N Sabbah; Paul J Hauptman; Wilson S Colucci
Journal:  Circulation       Date:  2008-08-19       Impact factor: 29.690

5.  Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.

Authors:  Paul J Hauptman; Peter J Schwartz; Michael R Gold; Martin Borggrefe; Dirk J Van Veldhuisen; Randall C Starling; Douglas L Mann
Journal:  Am Heart J       Date:  2012-06       Impact factor: 4.749

6.  Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon; Walter A Brzezinski; Keith C Ferdinand
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

7.  Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction.

Authors:  P J Schwartz; E Vanoli; M Stramba-Badiale; G M De Ferrari; G E Billman; R D Foreman
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

8.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

9.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

10.  SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

Authors:  Hitesh C Patel; Carl Hayward; Carlo Di Mario
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
View more
  6 in total

1.  Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling.

Authors:  Xueyuan Bi; Xi He; Man Xu; Ming Zhao; Xiaojiang Yu; Xingzhu Lu; Weijin Zang
Journal:  Cell Cycle       Date:  2015-06-11       Impact factor: 4.534

Review 2.  Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.

Authors:  Raven Voora; Alan L Hinderliter
Journal:  Curr Hypertens Rep       Date:  2018-09-07       Impact factor: 5.369

Review 3.  Gastrointestinal Tract: a Promising Target for the Management of Hypertension.

Authors:  Shiqiang Xiong; Qiang Li; Daoyan Liu; Zhiming Zhu
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

4.  Higher cardiac vagal activity predicts lower peripheral resistance 6 years later in European but not African Americans.

Authors:  DeWayne P Williams; Julian F Thayer; James D Halbert; Xiaoling Wang; Gaston Kapuku
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-26       Impact factor: 5.125

5.  Atrial GIRK Channels Mediate the Effects of Vagus Nerve Stimulation on Heart Rate Dynamics and Arrhythmogenesis.

Authors:  Steven W Lee; Allison Anderson; Pilar A Guzman; Atsushi Nakano; Elena G Tolkacheva; Kevin Wickman
Journal:  Front Physiol       Date:  2018-07-19       Impact factor: 4.566

6.  Chiropractic care for hypertension: Review of the literature and study of biological and genetic bases.

Authors:  Stephanie Gb Sullivan; Stefano Paolacci; Aysha Karim Kiani; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.